Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $947,749,846    

Indirect Value

   $2,892,026,755      
Total Shares   127,751,902      
Total Value   $3,839,776,601      


Synageva BioPharma Corp $0 XOMA Corporation $333,213,218 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,178,868 Incyte Corp $7,009,716 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,231,765 Kiniksa Pharmaceuticals, Ltd. $573,418 Synageva BioPharma Corp $0 XOMA Corporation $333,213,218 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,178,868 Incyte Corp $7,009,716 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,231,765 Kiniksa Pharmaceuticals, Ltd. $573,418
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    11   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   5.5   
   -1.0   
     Percentage Gain/Loss :
   19.7%
 -23.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp Director   –       •      –    2013-06-11 3 IO $0.00 $0 I/I 0 15,000 -
INCY Incyte Corp Director   –       •      –    2013-06-11 3 IO $0.00 $0 D/D 0 12,430,783 -
INCY Incyte Corp Director   –       •       •   2016-12-30 4 A $100.27 $56,853 I/I 567 533,909 0 -
INCY Incyte Corp Director   –       •       •   2017-03-31 4 A $133.67 $56,943 I/I 426 767,237 0 -
INCY Incyte Corp Director   –       •       •   2017-04-27 4 OE $7.26 $435,600 I/I 60,000 787,237 0 -
INCY Incyte Corp Director   –       •       •   2017-09-08 4 B $132.00 $13,200,000 I/I 100,000 789,416 2.25 -
KNSA Kiniksa Pharmaceuticals, ... Director   –       •      –    2022-06-29 4 A $0.00 $0 I/I 20,000 2,710,597 0 -
KNSA Kiniksa Pharmaceuticals, ... Director   –       •      –    2023-06-06 4 A $0.00 $0 I/I 17,492 2,719,343 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-13 4 B $136.18 $10,001,368 I/I 69,839 1,465,494 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $156.42 $5,347,837 I/I 34,188 1,531,757 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $152.21 $5,799,653 I/I 37,660 1,500,227 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-15 4 B $161.97 $2,461,721 I/I 15,199 1,545,775 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-17 4 B $167.63 $8,100,704 I/I 46,370 1,588,541 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-20 4 B $181.93 $3,846,575 I/I 20,709 1,607,668 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-21 4 B $183.16 $12,128,340 I/I 64,350 1,667,104 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-12 4 B $205.32 $7,548,616 I/I 34,578 1,699,129 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-13 4 B $216.70 $17,805,684 I/I 81,159 1,774,294 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-14 4 B $226.97 $4,710,893 I/I 20,633 1,793,403 2.1 %
SGEN Seagen Inc Director   –       •      –    2013-05-17 3 IO $0.00 $0 D/D 0 15,131,223 -
SGEN Seagen Inc Director   –       •       •   2014-12-15 4 B $31.41 $30,861,290 I/I 973,399 22,083,165 2.25 -
SGEN Seagen Inc Director   –       •       •   2014-12-16 4 B $30.80 $60,997,873 I/I 1,909,979 23,993,144 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-02-24 4 B $33.60 $7,341,491 I/I 217,465 24,210,609 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-02-25 4 B $34.46 $2,194,758 I/I 63,650 24,274,259 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-03-03 4 B $34.76 $14,814,701 I/I 425,220 24,699,479 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-03-04 4 B $34.79 $822,418 I/I 23,621 24,723,100 2.25 -
  114  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us